Mastodawn

Xamanismo Coletivo May 12, 2025

#JoeRogan interviews #RickDoblin, Ph.D., the founder and president of the Multidisciplinary Association for Psychedelic Studies (#MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated #Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for #PTSD.

https://pca.st/episode/b5a28389-32a6-48b3-93c5-5c63477d768b

Web Player - Pocket Casts

Listen to your favorite podcasts online, in your browser. Discover the world's most powerful podcast player.

Xamanismo Coletivo Feb 7, 2025

From where I stand, the linked article below looks like an opportunistic partisan move. In my view, people from both sides of the dispute (#MAPS AND #Psymposia) managed to slow down the progress of #psychedelicMedicine (maybe for good).
But I agree with Ms. Devenot that, specially by tagging #Left on the title, it is a "transparently partisan attack" that "politicized whistleblowers to appeal to the #Trump administration on behalf of a #pharmaceuticalcompany." (#Lykos)

https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.html?unlocked_article_code=1.vE4.fOfO.GlkdCIj0dlvk&smid=nytcore-ios-share&referringSource=articleShare

How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.

The New York Times

Watson Jan 28, 2025

For the neverending beauty of the Sfakia in the south west of Crete in Greece!!!
#sfakia #crete #greece #kreta #griechenland #nature #natur #lykos #likos #livaniana #aradena

Brittany Trang Aug 17, 2024

A @STAT exclusive: Rick Doblin's first interview after

• Lykos' #MDMA treatment was rejected by the FDA
• 3 of its papers were retracted
• #Lykos laid off workers + ejected Doblin from its board
• MAPS laid off workers

He came out firing.

https://www.statnews.com/2024/08/17/mdma-psychedelics-rick-doblin-lykos-exit

#psychedelics

Rick Doblin, 'unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and Drug Administration declined to approve the MDMA-assisted

STAT

Xamanismo Coletivo Aug 13, 2024

"The #FDA and its advisors identified flaws in the design of the clinical trials, missing data, and a variety of biases in people involved with the trials, including an alleged cult-like support of #psychedelics. #Lykos is a commercial spinoff of the psychedelic advocacy nonprofit Multidisciplinary Association for Psychedelic Studies (#MAPS)."
https://arstechnica.com/science/2024/08/mdma-for-ptsd-three-studies-retracted-on-heels-of-fda-rejection/

MDMA for PTSD: Three studies retracted on heels of FDA rejection

The company behind the therapy says it will appeal the FDA's decision.

Ars Technica

Trending Tech Nieuws Aug 12, 2024

De controversiële retractie van mdma-studies voor ptsd behandeling https://www.trendingtech.news/trending-news/2024/08/28437/de-controversi-le-retractie-van-mdma-studies-voor-ptsd-behandeling #MDMA PTSD Behandeling #FDA Afwijzing MDMA #Wetenschappelijke Studies Retractie #Lykos Therapeutics Controversie #Psychedelische Therapie Ethiek #Trending #News #Nieuws

De controversiële retractie van mdma-studies voor ptsd behandeling

Het laatste, trending tech nieuws

Xamanismo Coletivo Aug 10, 2024

"#Lykos itself was bracing for a negative verdict from the agency amidst a number of negative appraisals in recent months. Those included one of #FDA’s own advisory committees pointing to flaws in the study design & conduct.
However, insiders are surprised by just how harsh FDA’s CRL appears to have been, with the agency requesting an additional Phase 3—a very, very tall ask for the small company."
#MDMA #PTSD
https://psychedelicalpha.com/news/breaking-fda-rejects-lykos-therapeutics-mdma-assisted-therapy-for-ptsd

BREAKING: FDA Rejects Lykos Therapeutics’ MDMA-Assisted Therapy For PTSD - Psychedelic Alpha

FDA has issued a Complete Response Letter (CRL) to Lykos Therapeutics’ regarding its New Drug Application (NDA) for MDMA-assisted therapy in PTSD, meaning the agency is not prepared to approve it at…

Psychedelic Alpha

Gentleman of Leisure Jun 4, 2024

😡👎

c’mon advisory panel! How the heck could Lykos blind an MDMA trial?! PTSD is a condition with severe unmet medical need and MDMA risks can be controlled. I’m really disappointed in this panel recommendation

#ptsd #MDMA #lykos #fda #fdaadvisorypanel

FDA panel recommends against approval of MDMA to treat PTSD https://www.washingtonpost.com/health/2024/06/04/mdma-fda-review-ptsd-treatment/